Bal Pharma Ltd

NSE:BALPHARMAHealthcare

₹91.68−4.25%At closeAt close · Mon 19 Oct · ≈ AED 3.54 · Market cap $15.33M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	40.2%	39.6%	41.2%	22.7%	24.1%	24.4%	—	—
Operating margin	5.7%	5.3%	5.8%	6.3%	6.5%	6.7%	6.7%	+0.0 pts
Net margin	1.9%	2.0%	0.8%	2.2%	2.4%	2.0%	2.0%	+0.0 pts
EBITDA margin	10.4%	8.5%	8.1%	9.4%	10.5%	10.9%	—	—
Return on equity	8.9%	9.6%	4.0%	10.7%	9.3%	7.6%	7.6%	−0.0 pts
Return on assets	2.0%	2.2%	0.8%	2.3%	2.1%	1.7%	1.7%	+0.0 pts
Return on capital employed	16.1%	15.7%	17.1%	18.4%	17.0%	16.5%	—	—
Debt / equity	2.1×	1.8×	2.1×	2.1×	1.9×	1.9×	1.9×	−0.0%
Debt / assets	46.6%	40.9%	42.5%	44.5%	44.8%	42.5%	—	—
Interest coverage	1.2×	1.4×	1.7×	1.4×	1.2×	1.2×	—	—
Current ratio	1.1×	1.1×	1.1×	1.2×	1.1×	1.1×	1.1×	+0.0%
Quick ratio	0.7×	0.7×	0.6×	0.7×	0.6×	0.6×	—	—
Cash ratio	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Asset turnover	1.0×	1.1×	1.0×	1.1×	0.9×	0.8×	—	—
Inventory turnover	2.5×	2.3×	1.8×	3.0×	2.4×	2.0×	—	—
Receivables turnover	3.3×	3.4×	3.1×	3.4×	3.2×	3.3×	—	—
Dividend payout	6.1%	26.4%	60.5%	21.2%	26.5%	30.4%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.